# ABBOTT LABORATORIES (ABT) FY2026 Q2 Balance Sheet

- Company: ABBOTT LABORATORIES (ABT)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-28, accession number 0001628280-26-050134
- Page: https://plicit.ai/financials/abt/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/abt-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 109,215,000,000 US dollars
- **Current assets**: 24,517,000,000 US dollars
- **Non-current assets**: 84,698,000,000 US dollars
- **Liabilities (calculated)**: 57,453,000,000 US dollars
- **Current liabilities**: 17,814,000,000 US dollars
- **Non-current liabilities**: 39,639,000,000 US dollars
- **Equity**: 51,762,000,000 US dollars
- **Noncontrolling interest**: 652,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Property and equipment, at cost**: 26,469,000,000 US dollars. Part of Net property and equipment, drawn as one net amount.
- **Less: accumulated depreciation and amortization**: negative 13,657,000,000 US dollars. Part of Net property and equipment, drawn as one net amount.
- **Trade receivables, less allowances of $486 in 2026 and $490 in 2025**: 8,599,000,000 US dollars
- **Cash and cash equivalents**: 5,104,000,000 US dollars
- **Finished products**: 4,512,000,000 US dollars
- **Prepaid expenses and other receivables**: 3,000,000,000 US dollars
- **Materials**: 1,780,000,000 US dollars
- **Work in process**: 1,023,000,000 US dollars
- **Short-term investments**: 499,000,000 US dollars
- **Goodwill**: 35,244,000,000 US dollars
- **Deferred income taxes and other assets**: 18,320,000,000 US dollars
- **Intangible assets, net of amortization**: 17,211,000,000 US dollars
- **Net property and equipment**: 12,812,000,000 US dollars
- **Investments**: 1,111,000,000 US dollars
- **Other accrued liabilities**: 6,892,000,000 US dollars
- **Trade accounts payable**: 4,794,000,000 US dollars
- **Current portion of long-term debt**: 3,005,000,000 US dollars
- **Salaries, wages, and commissions**: 1,619,000,000 US dollars
- **Dividends payable**: 1,093,000,000 US dollars
- **Income taxes payable**: 411,000,000 US dollars
- **Long-term debt**: 29,603,000,000 US dollars
- **Post-employment obligations, deferred income taxes, and other long-term liabilities**: 10,036,000,000 US dollars
- **Earnings employed in the business**: 49,794,000,000 US dollars
- **Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2026: 1,998,291,279; 2025: 1,996,795,525**: 25,495,000,000 US dollars
- **Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued**: 0 US dollars
- **Noncontrolling interests**: 652,000,000 US dollars
- **Common shares held in treasury, at cost — Shares: 2026: 267,907,258; 2025: 260,196,074**: negative 17,967,000,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 6,212,000,000 US dollars
- **Gross equity (calculated)**: 75,941,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.